A detailed history of Jump Financial, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 21,589 shares of TRVI stock, worth $97,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,589
Holding current value
$97,582
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$2.53 - $4.5 $54,620 - $97,150
21,589 New
21,589 $91,000
Q1 2024

May 13, 2024

BUY
$1.3 - $3.7 $23,973 - $68,231
18,441 New
18,441 $63,000
Q3 2022

Nov 07, 2022

BUY
$1.54 - $4.28 $66,184 - $183,941
42,977 New
42,977 $66,000

Others Institutions Holding TRVI

About Trevi Therapeutics, Inc.


  • Ticker TRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,322,500
  • Market Cap $264M
  • Description
  • Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...
More about TRVI
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.